Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
View the AEZS historical prices.
The 52 Week Low is $1.36 set on Thu, Mar 28, 2024.
The 52 Week High is $3.38 set on Thu, Mar 28, 2024. The current price, $2.08, is 0% below the 52 Week High.
The All-Time High is $0.00 set on Thu, Mar 28, 2024. The current price, $2.08, is 0% below the All Time High.
AEZS has no dividend history.
Annual Dividend Yield
Quarterly Dividend Rate
Declaration Date
Ex-Dividend Date
Record Date
Payment Date
Dividend Frequency
Dividend History
AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland.
Did you know you can earn $30 back on your first $30 of qualifying purchases with Rakuten?
Join now and start saving on every purchase from top retailers like Target, eBay, Zappos, Walmart, Kohl's & CVS. Whether you're shopping for fashion, electronics, home essentials, or health products, Rakuten makes it rewarding.
Sign up through this link and explore the endless possibilities to save and earn cash back!
Check out the Symbol Surfing blog to learn about investing.